Академический Документы
Профессиональный Документы
Культура Документы
Dr. Cristian Serafinceanu Institutul de Diabet, Nutriie i Boli metabolice N. Paulescu Bucharest
Identification of therapeutic goals: 1. Reasonable acceptable 2. Negotiable for own lifestyle 3. Adjustable
Significant antecedents:
Physiologic Pathologic Therapeutic
2. 3. 4.
Known nutritional problems or deficits Chronic use of drugs with nutritional effects (i.e. chimiotherapy) Psycho-social antecedents:
Alcohol or drug abuse Smoking Financial and social status Marital status
5. 6.
Specific signs and symptoms for nutritional deficiencies Subjective global assessment:
Evaluation of muscular waste Evaluation of subcutaneous tissue Presence of oedemas Dialysis related items
Nutritional screening I
Basal (level I): detection of nutritional risk factors -body mass index -eating habits -living environment -functional status Complete (level II): for patients at nutritional risk -history of weight changes (6 mo) -mid-arm circumference -triceps skinfold -mid-arm muscle area -serum albumin -total plasma cholesterol -clinical features -drug prescriptions -mental/cognitive status
Reference values for classifying severity of malnutrition in body mass index (BMI)
Age BMI
<16 16 16,9 17 18,5 >= 18,6 <16,5
Malnutrition
Severe Moderate Mild Normal Present
>= 18 years
14 17 years
11 13 years
<15
Present
Nutritional screening II
Eating habits (topics)
-not have to eat enough (each day) -usually eats alone -poor appetite -special (restrictive) diets -does not eat vegetables, fruit or milk at least once daily -difficulties in chewing or swallowing -more than two alcoholic drinks per day (one for women) -has pain in mouth , teeth or gums
-poor income
-lives alone -housebound -is unable (or prefers not) to spend money on food
Nutritional screening IV
Functional status - needs assistance (usually or always) with:
-bathing -dressing -toileting (grooming) -eating (preparing food) -walking (traveling) -shopping (for food)
Nutritional screening V- reference values for anthropometric measurements in adults (adapted from Hammond KA et col, 2004)
Target population
Females 30-40y
Females 60-70y
31.7
14.5
35.4
Males 30-40y
31.9
13
55.8
Males 60-70y
32.8
14.2
51
Nutritional screening VI
Clinical features and mental/cognitive status: -evident problems with mouth, teeth, gums -difficulties with chewing -angular stomatitis -glossitis -skin lesions (dry, loose, wounds, etc.) -history of bone fractures -clinical evidence of mental status impairment -depressive illness (Geriatric Depression Scale, etc.)
Decreased utilization
Various
Alcohol abuse
Blood loss Centesis (ascitic, pleural) Increased losses Uncontrolled diabetes mellitus Diarrhea Nephrotic syndrome Dialysis
Magnesium, zinc
Iron Protein Energy, protein Protein, electrolytes Protein Protein, vitamins (water soluble)
Fever, hyperthyroidism
Physiologic demands (adolescence, pregnancy, lactation) Surgery, burns, trauma Infection, hypoxia Smoking
Increased requirements
Nutritional deficiency
essential fats, vit.A
Non-nutritional association
environmental chemical burns, Addisons disease hemorrhage, pigmentation disorders Liver disease, aspirin overdose pulmonary or heart chronic disease hypothyroidism, chemotherapy, psoriasis
Skin
nails
hair
Abnormal finding
dry, grayish, night blindness bilateral (angular stomatitis) or vertical cracks (cheilosis) magenta, loss of papillae, swollen
Nutritional deficiency
Vit A
Non-nutritional association
Gauchers disease
lips
tongue
Vit B2
gums
Vit. C
parotid glands
Bilateral enlargement
Protein deficiency
visceral
somatic
SGA
expenditure
balance
Anthropometry BIA Nitrogen balance Densitometry Creat. Kinetics Isotope studies DEXA NMR others
Normal function
Coloid-osmotic pressure
Nutritional significance
late malnutrition marker
Albumin
Transferrin
2.6-4.3
8-9
Prealbumin (transthyretin) Rhetynol binding protein (RBP) Insulin-like growth factor 1 (IGF 1)
0.2-0.4
2-3
0.37
0.5 (12h)
0.55-1.4 UI/ml
2-6 h
Serum prealbumin
Serum transferrin
Retinol-binding protein
Limited availability, expensive Influenced by renal function, inflammation Decreased by hypertiroidism and vit. A defficiency Limited availability, expensive Acute influenced by dietary intake No evidence based data
Serum IGF-1
Subjective Global Assessment (from Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, 1987, What is subjective global assessment, Journal of American Medical Association 271:54-58)
1. Weight Change
Maximum body weight _______________ Weight 6 months ago _______________ Current weight _______________
% Wt change
Overall weight loss in past 6 months _______________ Percent weight loss in past 6 months _______________ Change in past weeks: _______increase _______no change ________decrease
Subjective Global Assessment II ( from Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, 1987, What is subjective global assessment, Journal of American Medical Association 271:54-58)
4. Functional Capacity
___________ NO dysfunction ___________ Dysfunction Duration: ____________ weeks Type: ____________ Works suboptimally ____________ Ambulatory ____________ Bedridden
PHYSICAL EXAMINATION
(For each trait specify: 0 = normal; 1+ = mild; 2+ = moderate; 3+ = severe) __________ Loss of subcutaneous fat (shoulders, triceps, chest, hands) __________ Muscle wasting (quadriceps, deltoids) __________ Ankle edema __________ Ascites
no
Anorexia
Walking difficulty
Bedriding
Anthropometric assessment of nutritional status II 2. Body mass index (BMI, Quetelet index) 3. Tricipital skinfold (TS) 4. Mid-arm circumference (MAC) 5.Mid-arm muscular area (MAMA) (MAC - TS)2/12.56
Protein status: central for the prevention, diagnosis and treatment of malnutrition:
Bi - compartmental pattern (of evaluation):
Metabolic active proteins (30 50%)
Muscle (somatic) proteins (75%) Visceral proteins (25%)
2. 3. 4.
Disequilibrium of nitrogen balance need dietary and/or non dietary correction (i.e.: increased losses in critically ill patients).
Expected 24 hour urinary creatinine values for height in adults (after Blackburn GL, Bistrian BR, Maini BS et al, 1977)
Males Height (cm) 160 165 Urinary creatinine /24h (mg) 1325 1386 Females Height (cm) 150 155 Urinary creatinine /24h (mg) 851 900
170
180 185 190
1467
1642 1739 1831
160
165 170 175
950
1001 1076 1141